Free Trial

abrdn Life Sciences Investors (HQL) SEC Filings & 10K Form

abrdn Life Sciences Investors logo
$13.88 -0.04 (-0.25%)
As of 11:14 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent abrdn Life Sciences Investors SEC Filings

DateFilerForm TypeView
08/28/2025
3:24 PM
abrdn Life Sciences Investors (Filer)
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
08/27/2025
4:45 PM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2025
8:43 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2025
1:40 PM
abrdn Life Sciences Investors (Issuer)
Dietrick Joseph Francis (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/09/2025
1:15 PM
abrdn Life Sciences Investors (Filer)
Form N-CSRS
05/22/2025
5:22 PM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:47 PM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
4:54 PM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
6:39 PM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
9:17 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
8:41 AM
abrdn Life Sciences Investors (Subject)
FIRST TRUST PORTFOLIOS LP (Filed by)
Form SCHEDULE 13G
04/21/2025
7:54 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
9:20 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
2:59 PM
abrdn Healthcare Investors (Filer)
abrdn Healthcare Opportunities Fund (Filer)
abrdn Life Sciences Investors (Filer)
abrdn World Healthcare Fund (Filer)
Form DEF 14A
04/14/2025
11:33 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
11:30 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:49 PM
abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SCHEDULE 13D/A
03/31/2025
11:07 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
10:47 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:33 PM
abrdn Life Sciences Investors (Issuer)
Gebauer Katie Lynn (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2025
3:35 PM
abrdn Life Sciences Investors (Issuer)
Hepp Robert W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2025
3:19 PM
abrdn Life Sciences Investors (Issuer)
Taggart Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2025
3:22 PM
abrdn Life Sciences Investors (Issuer)
Marsico Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2025
3:27 PM
abrdn Life Sciences Investors (Issuer)
Hasson Heather (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/28/2025
1:49 PM
abrdn Life Sciences Investors (Filer)
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
02/27/2025
9:09 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
12:09 PM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
6:45 PM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
12:00 PM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
9:39 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
2:30 PM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
9:57 AM
abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
12:19 PM
abrdn Life Sciences Investors (Issuer)
Wilson Ashton (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2024
12:20 PM
abrdn Life Sciences Investors (Issuer)
Silue Kolotioloma (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
10:48 AM
abrdn Life Sciences Investors (Filer)
Form N-CEN
Annual Report for Registered Investment Companies
12/09/2024
12:05 PM
abrdn Life Sciences Investors (Filer)
Form N-CSR
Certified shareholder report of registered management investment companies  
11/27/2024
9:59 AM
abrdn Life Sciences Investors (Filer)
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:HQL) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners